ESTRONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Estrone, and what generic alternatives are available?
Estrone is a drug marketed by Dr Reddys and Watson Labs and is included in two NDAs.
The generic ingredient in ESTRONE is estrone. There are nine drug master file entries for this compound. Additional details are available on the estrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ESTRONE?
- What are the global sales for ESTRONE?
- What is Average Wholesale Price for ESTRONE?
Summary for ESTRONE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 106 |
| Clinical Trials: | 47 |
| Patent Applications: | 3,534 |
| DailyMed Link: | ESTRONE at DailyMed |
Recent Clinical Trials for ESTRONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Science Valley Research Institute | N/A |
| Biòs Farmacêutica | N/A |
| University of Maryland, Baltimore | Early Phase 1 |
Medical Subject Heading (MeSH) Categories for ESTRONE
Anatomical Therapeutic Chemical (ATC) Classes for ESTRONE
US Patents and Regulatory Information for ESTRONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys | ESTRONE | estrone | INJECTABLE;INJECTION | 085239-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | ESTRONE | estrone | INJECTABLE;INJECTION | 083397-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
